NovoCure Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	642.27	605.22	509.34	537.84	535.03	494.37	Upgrade
Revenue Growth (YoY)	11.17%	18.82%	-5.30%	0.53%	8.23%	40.72%	Upgrade
Cost of Revenue	157.18	136.18	127.54	114.26	114.24	106.09	Upgrade
Gross Profit	485.09	469.05	381.8	423.58	420.79	388.27	Upgrade
Selling, General & Admin	441.97	427.21	386.97	306.41	263.18	225.45	Upgrade
Research & Development	214.57	209.37	220.99	206.09	201.3	132.01	Upgrade
Operating Expenses	656.54	636.58	607.96	512.5	464.49	357.46	Upgrade
Operating Income	-171.45	-167.54	-226.16	-88.91	-43.69	30.81	Upgrade
Interest Expense	-13.67	-10.34	-3.32	-3.33	-3.44	-17.58	Upgrade
Interest & Investment Income	14.07	22.72	19.64	10.96	0.79	1.79	Upgrade
Currency Exchange Gain (Loss)	-0.72	-0.72	-0.8	-3.52	-4.03	2.65	Upgrade
Other Non Operating Income (Expenses)	-0.6	-0.6	-0.79	-1.26	-1.37	-0.47	Upgrade
EBT Excluding Unusual Items	-172.38	-156.48	-211.42	-86.06	-51.74	17.2	Upgrade
Merger & Restructuring Charges	-2	-2	-6.23	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	28.27	28.27	26.4	4.83	0.31	1.32	Upgrade
Asset Writedown	-0.95	-0.95	-0.48	-0.61	-0.64	-0.41	Upgrade
Other Unusual Items	-3.44	-	-	-	-	-	Upgrade
Pretax Income	-150.5	-131.16	-191.74	-81.85	-52.08	18.1	Upgrade
Income Tax Expense	27.15	37.47	15.3	10.69	6.28	-1.71	Upgrade
Net Income	-177.65	-168.63	-207.04	-92.53	-58.35	19.81	Upgrade
Net Income to Common	-177.65	-168.63	-207.04	-92.53	-58.35	19.81	Upgrade
Shares Outstanding (Basic)	111	108	106	105	103	101	Upgrade
Shares Outstanding (Diluted)	111	108	106	105	103	109	Upgrade
Shares Change (YoY)	2.82%	1.36%	1.65%	1.19%	-5.00%	11.97%	Upgrade
EPS (Basic)	-1.61	-1.56	-1.95	-0.88	-0.56	0.20	Upgrade
EPS (Diluted)	-1.61	-1.56	-1.95	-0.88	-0.56	0.18	Upgrade
Free Cash Flow	-65.17	-69.22	-100.43	9.43	58.59	84.18	Upgrade
Free Cash Flow Per Share	-0.59	-0.64	-0.94	0.09	0.57	0.77	Upgrade
Gross Margin	75.53%	77.50%	74.96%	78.76%	78.65%	78.54%	Upgrade
Operating Margin	-26.70%	-27.68%	-44.40%	-16.53%	-8.17%	6.23%	Upgrade
Profit Margin	-27.66%	-27.86%	-40.65%	-17.21%	-10.91%	4.01%	Upgrade
Free Cash Flow Margin	-10.15%	-11.44%	-19.72%	1.75%	10.95%	17.03%	Upgrade
EBITDA	-159.29	-157.67	-216.46	-79.34	-34.53	38.56	Upgrade
EBITDA Margin	-24.80%	-26.05%	-42.50%	-14.75%	-6.45%	7.80%	Upgrade
D&A For EBITDA	12.17	9.87	9.7	9.57	9.17	7.75	Upgrade
EBIT	-171.45	-167.54	-226.16	-88.91	-43.69	30.81	Upgrade
EBIT Margin	-26.70%	-27.68%	-44.40%	-16.53%	-8.17%	6.23%	Upgrade

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q